Related Experiment Videos
The human heart endothelin system: ET-1 synthesis, storage, release and effect
1Department of Medicine, University of Queensland, The Prince Charles Hospital, Chermside, Queensland 4032, Australia. russell@medicine.uq.edu.au
Trends in Pharmacological Sciences
|September 6, 2000
Summary
Endothelin-1 (ET-1) in the human heart affects contractility via ETA and ETB receptors. This system may support or harm a failing heart, suggesting therapeutic potential for receptor antagonists.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Pharmacology
Background:
- Endothelin-1 (ET-1) is endogenously produced and released within the human heart.
- ET-1 exerts direct paracrine effects on cardiac function by activating specific receptors.
Purpose of the Study:
- To investigate the localization and functional roles of endothelin receptors (ETA and ETB) in the human heart.
- To explore the dual role of the endothelin system in supporting and potentially causing pathology in the failing heart.
Main Methods:
- Localization studies of endothelin ETA and ETB binding sites in human cardiac tissue.
- Assessment of receptor involvement in modulating cardiac contractility in different heart chambers.
Main Results:
- Both ETA and ETB receptors are present in the human heart.
- ETA receptors influence left ventricular contractility.
- ETA, ETB, and potentially novel receptor conformations modulate right atrial contractility.
Conclusions:
- The endothelin system plays a significant role in human heart function and contractility.
- The endothelin system's involvement in heart failure presents a therapeutic target.
- Endothelin receptor antagonists offer a potential treatment strategy for cardiac conditions.